An American biotechnology company, Moderna Inc (Nasdaq:MRNA) disclosed that the Company speed up its efforts to develop COVID-19 vaccine for combating the pandemic.
After the FDA approval for Phase 2 clinical trials, Moderna plans to commence Phase 2 clinical trials for its COVID-19 vaccine shortly while Phase 3 clinical trials are probable to begin in upcoming months.
Shares of Moderna jumped 8% to close the day’s trade at USD 53.19 on 7 May 2020.
Disclaimer
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.
